The US regulators continue to focus their attention on the investment activities of investment advisers and private funds. These efforts are not limited to the newly adopted and proposed rules by the Securities and Exchange Commission. Rather, recent enforcement and new and proposed regulatory changes by the Department of Justice (DOJ) and the Federal Trade Commission (FTC), have made it clear that the antitrust enforcers will continue to scrutinize fund activities that trigger antitrust concerns, particularly as investors decide to engage more actively in target companies. From the revised Merger Guidelines, to the proposed overhaul of the HSR premerger notification filing requirements, to the recently announced investigations and stepped up enforcement of interlocking directorates under Section 8 of the Clayton Act and HSR Act violations, private funds and their investment advisors must pay attention to these developments and carefully consider their activities vis a vis the companies they invest in to ensure compliance and mitigate regulatory risk.
Join the thought leaders from the Managed Funds Association and Lowenstein Sandler’s Antitrust/Competition and Investment Management practices for an in-depth review of these recent developments and various other considerations that will be helpful to investment advisers, private funds, and their legal and compliance teams.
CLE credit will be provided for CA, NJ, and NY.
Speakers:
- Zarema A. Jaramillo, Partner; Office Managing Partner, Washington, D.C. Office, Lowenstein Sandler LLP
- Jonathan A. Danziger, Partner, Lowenstein Sandler LLP
- Jennifer Han, Executive Vice President, Chief Counsel, Head of Global Regulatory Affairs, Managed Funds Association
Time: 12-1:30 p.m. ET
Location: Lowenstein Sandler LLP, 1251 Avenue of the Americas, 17th Fl, New York, NY 10020
